Levels and changes in key diagnostic and treatment indicators - performance of the new case-management policy (analysis at all health facilities) and health workers adherence to guidelines (analysis at facilities with available diagnostics and AL).

AL = artemether-lumefantrine; AM = antimalarial; QN = quinine; SP = sulfadoxine-pyrimethamine; AS = artesunate; AQ = amodiaquine; DHA = dihydroartemisinin; ART = artemether.aDefined as management of febrile patient meeting all of the following three criteria: 1) patient tested for malaria; 2) if positive test result treated with AL, and 3) if negative test not treated for malaria.bDenominators in this category include 295 patients at baseline and 212 at follow-up surveys.cDenominators in this category include 280 patients at baseline and 238 at follow-up surveys.dOther antimalarial treatment include QN (18), SP (3), AS+AQ (2), DHA (2), QN+SP (2), ART (1) and AL+SP (1).eOther antimalarial treatment include AL+QN (8), QN (6), AQ (3) and AL+SP (1).fOther antimalarial treatment include AL+QN (28), SP (28), QN (14), AQ (4) and DHA (1).